274 related articles for article (PubMed ID: 20858963)
1. EEG, activity, and sleep architecture in a transgenic AβPPswe/PSEN1A246E Alzheimer's disease mouse.
Jyoti A; Plano A; Riedel G; Platt B
J Alzheimers Dis; 2010; 22(3):873-87. PubMed ID: 20858963
[TBL] [Abstract][Full Text] [Related]
2. Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576.
Kent BA; Strittmatter SM; Nygaard HB
J Alzheimers Dis; 2018; 64(4):1325-1336. PubMed ID: 29991134
[TBL] [Abstract][Full Text] [Related]
3. Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease.
Duncan MJ; Smith JT; Franklin KM; Beckett TL; Murphy MP; St Clair DK; Donohue KD; Striz M; O'Hara BF
Exp Neurol; 2012 Aug; 236(2):249-58. PubMed ID: 22634208
[TBL] [Abstract][Full Text] [Related]
4. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure.
Hahn S; Brüning T; Ness J; Czirr E; Baches S; Gijsen H; Korth C; Pietrzik CU; Bulic B; Weggen S
J Neurochem; 2011 Feb; 116(3):385-95. PubMed ID: 21091478
[TBL] [Abstract][Full Text] [Related]
5. Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon.
Baño Otalora B; Popovic N; Gambini J; Popovic M; Viña J; Bonet-Costa V; Reiter RJ; Camello PJ; Rol MÁ; Madrid JA
Chronobiol Int; 2012 Aug; 29(7):822-34. PubMed ID: 22823866
[TBL] [Abstract][Full Text] [Related]
6. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission.
Wisor JP; Edgar DM; Yesavage J; Ryan HS; McCormick CM; Lapustea N; Murphy GM
Neuroscience; 2005; 131(2):375-85. PubMed ID: 15708480
[TBL] [Abstract][Full Text] [Related]
7. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease.
Pugh PL; Richardson JC; Bate ST; Upton N; Sunter D
Behav Brain Res; 2007 Mar; 178(1):18-28. PubMed ID: 17229472
[TBL] [Abstract][Full Text] [Related]
8. Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus.
Baglietto-Vargas D; Moreno-Gonzalez I; Sanchez-Varo R; Jimenez S; Trujillo-Estrada L; Sanchez-Mejias E; Torres M; Romero-Acebal M; Ruano D; Vizuete M; Vitorica J; Gutierrez A
J Alzheimers Dis; 2010; 21(1):119-32. PubMed ID: 20413859
[TBL] [Abstract][Full Text] [Related]
9. Behavioral and EEG changes in male 5xFAD mice.
Schneider F; Baldauf K; Wetzel W; Reymann KG
Physiol Behav; 2014 Aug; 135():25-33. PubMed ID: 24907698
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
11. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.
Faivre E; Hölscher C
J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes.
Sterniczuk R; Dyck RH; Laferla FM; Antle MC
Brain Res; 2010 Aug; 1348():139-48. PubMed ID: 20471965
[TBL] [Abstract][Full Text] [Related]
13. The GABAA receptor agonist THIP alters the EEG in waking and sleep of mice.
Vyazovskiy VV; Kopp C; Bösch G; Tobler I
Neuropharmacology; 2005 Apr; 48(5):617-26. PubMed ID: 15814097
[TBL] [Abstract][Full Text] [Related]
14. Lesion-induced hippocampal plasticity in transgenic Alzheimer's disease mouse models: influences of age, genotype, and estrogen.
Kadish I; van Groen T
J Alzheimers Dis; 2009; 18(2):429-45. PubMed ID: 19584452
[TBL] [Abstract][Full Text] [Related]
15. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
[TBL] [Abstract][Full Text] [Related]
16. The EEG effects of THIP (Gaboxadol) on sleep and waking are mediated by the GABA(A)delta-subunit-containing receptors.
Winsky-Sommerer R; Vyazovskiy VV; Homanics GE; Tobler I
Eur J Neurosci; 2007 Mar; 25(6):1893-9. PubMed ID: 17408425
[TBL] [Abstract][Full Text] [Related]
17. Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer's disease.
Thomas P; Wang YJ; Zhong JH; Kosaraju S; O'Callaghan NJ; Zhou XF; Fenech M
Mutat Res; 2009 Feb; 661(1-2):25-34. PubMed ID: 19027755
[TBL] [Abstract][Full Text] [Related]
18. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L
J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581
[TBL] [Abstract][Full Text] [Related]
19. Interrelations and circadian changes of electroencephalogram frequencies under baseline conditions and constant sleep pressure in the rat.
Yasenkov R; Deboer T
Neuroscience; 2011 Apr; 180():212-21. PubMed ID: 21303684
[TBL] [Abstract][Full Text] [Related]
20. Chronic allopregnanolone treatment accelerates Alzheimer's disease development in AβPP(Swe)PSEN1(ΔE9) mice.
Bengtsson SK; Johansson M; Bäckström T; Wang M
J Alzheimers Dis; 2012; 31(1):71-84. PubMed ID: 22495347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
